Literature DB >> 18612764

A case of posterior reversible encephalopathy during polyarteritis nodosa vasculitis.

Lorenzo Stanzani1, Laura Fusi, Antonella Gomitoni, Mauro Roncoroni, Paolo Villa, Giampiero Grampa.   

Abstract

Posterior reversible encephalopathy is a distinctive syndrome associated with different diseases and drugs. Disease evolution is frequently favorable with an adequate treatment. Damage typically involves parietal-occipital lobes even if a more anterior diffusion has been described. Here, we report the case of a woman affected by Polyarteritis Nodosa, who suddenly complicated with decreased consciousness and seizures, during an acute hypertensive state. MRI imaging showed increased T2 and FLAIR signal in posterior regions. Her neurological evolution was positive, according to arterial pressure correction, although the systemic vasculitis was still ongoing, hence affecting final prognosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18612764     DOI: 10.1007/s10072-008-0929-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  12 in total

Review 1.  Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed.

Authors:  V L Stott; M A Hurrell; T J Anderson
Journal:  Intern Med J       Date:  2005-02       Impact factor: 2.048

2.  Case 129: Polyarteritis nodosa.

Authors:  Erik S Rhodes; Joseph S Pekala; John M Gemery; Kevin W Dickey
Journal:  Radiology       Date:  2008-01       Impact factor: 11.105

3.  Encephalopathy associated with intravenous immunoglobulin treatment for Guillain-Barré syndrome.

Authors:  K Harkness; S J Howell; G A Davies-Jones
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

Review 4.  Cyclosporine neurotoxicity: a review.

Authors:  J M Gijtenbeek; M J van den Bent; C J Vecht
Journal:  J Neurol       Date:  1999-05       Impact factor: 4.849

Review 5.  Hypertensive emergencies.

Authors:  C J Vaughan; N Delanty
Journal:  Lancet       Date:  2000-07-29       Impact factor: 79.321

6.  Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease?

Authors:  K Raza; J Thambyrajah; J N Townend; A R Exley; C Hortas; A Filer; D M Carruthers; P A Bacon
Journal:  Circulation       Date:  2000-09-26       Impact factor: 29.690

7.  Posterior reversible encephalopathy syndrome in a child with bronchial asthma.

Authors:  Hirokazu Kurahashi; Akihisa Okumura; Teruko Koide; Yoshihiro Ando; Hidehiko Hirata; Miyuki Magota; Kazuyoshi Watabane
Journal:  Brain Dev       Date:  2006-04-17       Impact factor: 1.961

8.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

9.  Neuroradiologic findings in polyarteritis nodosa.

Authors:  J M Provenzale; N B Allen
Journal:  AJNR Am J Neuroradiol       Date:  1996 Jun-Jul       Impact factor: 3.825

10.  Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa.

Authors:  A D Filer; J M Gardner-Medwin; J Thambyrajah; K Raza; D M Carruthers; R J Stevens; L Liu; S E Lowe; J N Townend; P A Bacon
Journal:  Ann Rheum Dis       Date:  2003-02       Impact factor: 19.103

View more
  2 in total

Review 1.  Takayasu's arteritis and posterior reversible encephalopathy syndrome: a case-based review.

Authors:  Carlos Rodrigo Camara-Lemarroy; Jackeline Grace Lara-Campos; Eduardo Perez-Contreras; René Rodríguez-Gutiérrez; Dionicio Angel Galarza-Delgado
Journal:  Clin Rheumatol       Date:  2013-01-06       Impact factor: 2.980

Review 2.  Rheumatologic diseases and posterior reversible encephalopathy syndrome: two case reports and review of the literature.

Authors:  Anmol Dhillon; Celso Velazquez; Chokkalingam Siva
Journal:  Rheumatol Int       Date:  2012-07-24       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.